Citigroup’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.88K | Buy |
+923
| New | +$3.88K | ﹤0.01% | 4563 |
|
2025
Q1 | – | Sell |
-13
| Closed | -$50 | – | 4827 |
|
2024
Q4 | $50 | Buy |
13
+12
| +1,200% | +$46 | ﹤0.01% | 4843 |
|
2024
Q3 | $9 | Hold |
1
| – | – | ﹤0.01% | 4789 |
|
2024
Q2 | $10 | Hold |
1
| – | – | ﹤0.01% | 4732 |
|
2024
Q1 | $14 | Sell |
1
-1,554
| -100% | -$21.8K | ﹤0.01% | 4754 |
|
2023
Q4 | $17K | Hold |
1,555
| – | – | ﹤0.01% | 4283 |
|
2023
Q3 | $15.9K | Hold |
1,555
| – | – | ﹤0.01% | 3749 |
|
2023
Q2 | $24.5K | Hold |
1,555
| – | – | ﹤0.01% | 4228 |
|
2023
Q1 | $35.2K | Buy |
+1,555
| New | +$35.2K | ﹤0.01% | 3723 |
|
2022
Q4 | – | Sell |
-33
| Closed | -$1K | – | 4964 |
|
2022
Q3 | $1K | Sell |
33
-120
| -78% | -$3.64K | ﹤0.01% | 4794 |
|
2022
Q2 | $7K | Sell |
153
-1,225
| -89% | -$56K | ﹤0.01% | 4733 |
|
2022
Q1 | $127K | Sell |
1,378
-4,625
| -77% | -$426K | ﹤0.01% | 3622 |
|
2021
Q4 | $1.33M | Buy |
6,003
+1,676
| +39% | +$372K | ﹤0.01% | 2280 |
|
2021
Q3 | $1.5M | Sell |
4,327
-3,502
| -45% | -$1.21M | ﹤0.01% | 2100 |
|
2021
Q2 | $2.94M | Sell |
7,829
-5,224
| -40% | -$1.96M | ﹤0.01% | 1823 |
|
2021
Q1 | $4.05M | Buy |
13,053
+11,900
| +1,032% | +$3.69M | ﹤0.01% | 1466 |
|
2020
Q4 | $289K | Buy |
1,153
+963
| +507% | +$241K | ﹤0.01% | 3004 |
|
2020
Q3 | $35K | Sell |
190
-379
| -67% | -$69.8K | ﹤0.01% | 3662 |
|
2020
Q2 | $142K | Buy |
569
+36
| +7% | +$8.98K | ﹤0.01% | 3258 |
|
2020
Q1 | $96K | Buy |
533
+104
| +24% | +$18.7K | ﹤0.01% | 3317 |
|
2019
Q4 | $179K | Buy |
429
+328
| +325% | +$137K | ﹤0.01% | 3203 |
|
2019
Q3 | $25K | Sell |
101
-97
| -49% | -$24K | ﹤0.01% | 4140 |
|
2019
Q2 | $79K | Buy |
198
+194
| +4,850% | +$77.4K | ﹤0.01% | 3781 |
|
2019
Q1 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 4970 |
|